Freeman Daniel, Dunn Graham, Startup Helen, Pugh Katherine, Cordwell Jacinta, Mander Helen, Černis Emma, Wingham Gail, Shirvell Katherine, Kingdon David
Department of Psychiatry, University of Oxford, Oxford, UK.
Centre for Biostatistics, Institute of Population Health, University of Manchester, Manchester, UK; Medical Research Council NorthWest Hub for Trials Methodology Research, Department of Biostatistics, University of Liverpool, Liverpool, UK.
Lancet Psychiatry. 2015 Apr;2(4):305-13. doi: 10.1016/S2215-0366(15)00039-5. Epub 2015 Mar 31.
Worry might be a contributory causal factor in the occurrence of persecutory delusions in patients with psychotic disorders. Therefore we postulated that reducing worry with cognitive behaviour therapy (CBT) would reduce persecutory delusions.
For our two-arm, assessor-blinded, randomised controlled trial (Worry Intervention Trial [WIT]), we recruited patients aged 18-65 years with persistent persecutory delusions but non-affective psychosis from two centres: the Oxford Health National Health Service (NHS) Foundation Trust (Oxford, UK) and the Southern Health NHS Foundation Trust (Southampton, UK). The key inclusion criteria for participants were a score of at least 3 on the Psychotic Symptoms Rating Scale (PSYRATS) denoting a current persecutory delusion; that the delusion had persisted for at least 3 months; a clinical diagnosis of schizophrenia, schizoaffective disorder, or delusional disorder; and a clinically significant level of worry. We randomly assigned (1:1) eligible patients, using a randomly permuted block procedure with variable block sizes and division by four strata, to either six sessions of worry-reduction CBT intervention done over 8 weeks added to standard care (the CBT-intervention group), or to standard care alone (the control group). The assessors were masked to patient allocations and did their assessments at week 0 (baseline), 8 weeks (end of treatment), and 24 weeks, follow-up. The primary outcomes were worry measured by the Penn State Worry Questionnaire (PSWQ) and delusions measured by the PSYRATS-delusion scale; we did the analyses in the intention-to-treat population, and also did a planned mediation analysis. This trial is registered with the ISRCTN Registry (number ISRCTN23197625) and is closed to new participants.
From Nov 1, 2011, to Sept 9, 2013, we recruited 150 eligible participants and randomly assigned 73 to the CBT intervention group, and 77 to the control group. 143 patients (95%) provided primary outcome follow-up data. Compared with standard care alone, at 8 weeks the CBT intervention significantly reduced worry (mean difference 6·35 [SE 1·56] PSWQ units, 95% CI 3·30-9·40; p<0·001) and persecutory delusions (2·08 [SE 0·73] PSYRATS units, 95% CI 0·64-3·51; p=0·005). The reductions were maintained to 24 weeks follow-up. The mediation analysis suggested that the change in worry accounted for 66% of the change in delusion. No patients died or were admitted to secure units during our study. Six suicide attempts (two in the CBT intervention group, and four in the control group) and two serious violent incidents (one in each group) were noted, but no adverse events were deemed related to the treatments or the assessments.
To our knowledge, this is the first large trial focused on persecutory delusions. We have shown that long-standing delusions were significantly reduced by a brief intervention targeted on worry, although the limitations for our study include no determination of the key elements within the intervention. Our results suggest that worry might cause paranoia, and that worry intervention techniques might be a beneficial addition to the standard treatment of psychosis.
Efficacy and Mechanism Evaluation programme, which is a UK Medical Research Council and National Institute of Health Research partnership.
担忧可能是精神障碍患者被害妄想发生的一个促成因素。因此,我们推测采用认知行为疗法(CBT)减轻担忧会减少被害妄想。
在我们的双臂、评估者盲法、随机对照试验(担忧干预试验[WIT])中,我们从两个中心招募了年龄在18 - 65岁、患有持续性被害妄想但无情感性精神病的患者:牛津健康国民保健服务(NHS)基金会信托机构(英国牛津)和南安普敦健康NHS基金会信托机构(英国南安普敦)。参与者的关键纳入标准是在精神病症状评定量表(PSYRATS)上得分至少为3分,表示当前存在被害妄想;妄想持续至少3个月;精神分裂症、分裂情感性障碍或妄想性障碍的临床诊断;以及具有临床显著水平的担忧。我们使用随机排列的区组程序,采用不同的区组大小并按四个层次进行划分,将符合条件的患者以1:1的比例随机分配到在8周内进行六次减轻担忧的CBT干预并加用标准护理的组(CBT干预组),或仅接受标准护理的组(对照组)。评估者对患者的分配情况不知情,并在第0周(基线)、第8周(治疗结束)和第24周随访时进行评估。主要结局是用宾夕法尼亚州立大学担忧问卷(PSWQ)测量的担忧和用PSYRATS - 妄想量表测量的妄想;我们在意向性治疗人群中进行分析,并且还进行了一项计划好的中介分析。该试验已在国际标准随机对照试验编号注册库(编号ISRCTN23197625)注册,并且不再招募新参与者。
从2011年11月1日至2013年9月9日,我们招募了150名符合条件的参与者,随机将73名分配到CBT干预组,77名分配到对照组。143名患者(95%)提供了主要结局随访数据。与仅接受标准护理相比,在第8周时,CBT干预显著减轻了担忧(平均差值6.35[标准误1.56]PSWQ单位,95%置信区间3.30 - 9.40;p<0.001)和被害妄想(2.08[标准误0.73]PSYRATS单位,95%置信区间0.64 - 3.51;p = 0.005)。这些减轻效果维持到24周随访。中介分析表明,担忧的变化占妄想变化的66%。在我们的研究期间,没有患者死亡或被收治到安全病房。记录到6次自杀未遂(CBT干预组2次,对照组4次)和2起严重暴力事件(每组各1起),但没有不良事件被认为与治疗或评估有关。
据我们所知,这是第一项专注于被害妄想的大型试验。我们已经表明,通过针对担忧的简短干预,长期存在的妄想显著减少,尽管我们研究的局限性包括未确定干预中的关键要素。我们的结果表明担忧可能导致偏执狂,并且担忧干预技术可能是精神病标准治疗中有益的补充。
疗效与机制评估项目,这是英国医学研究理事会和国家卫生研究院的合作项目。